Hepatitis Monthly

Published by: Kowsar

Association Between IL-10 Gene Promoter Polymorphisms (-592 A/C, -819 T/C, -1082 A/G) and Susceptibility to HBV Infection in an Iranian Population

Bita Moudi 1 , 2 , Zahra Heidari 1 , 2 , * , Hamidreza Mahmoudzadeh-Sagheb 1 , 2 , Mohammad Hashemi 3 , 4 , Malihe Metanat 1 , 5 , Soheila Khosravi 6 and Parisa Farrokh 7
Authors Information
1 Infectious Diseases and Tropical Medicine Research Center, Zahedan University of Medical Sciences, Zahedan, IR Iran
2 Department of Histology, School of Medicine, Zahedan University of Medical Sciences, Zahedan, IR Iran
3 Cellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, IR Iran
4 Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, IR Iran
5 Department of Infectious Diseases, School of Medicine, Zahedan University of Medical Sciences, Zahedan, IR Iran
6 Blood Transfusion Research Center, High Institute for Research and Education in Medicine, Zahedan, IR Iran
7 Department of Genetic, School of Biology, Damghan University, Damghan, IR Iran
Article information
  • Hepatitis Monthly: February 01, 2016, 16 (2); e32427
  • Published Online: February 20, 2016
  • Article Type: Research Article
  • Received: August 26, 2015
  • Revised: November 29, 2015
  • Accepted: January 9, 2016
  • DOI: 10.5812/hepatmon.32427

To Cite: Moudi B, Heidari Z, Mahmoudzadeh-Sagheb H, Hashemi M, Metanat M, et al. Association Between IL-10 Gene Promoter Polymorphisms (-592 A/C, -819 T/C, -1082 A/G) and Susceptibility to HBV Infection in an Iranian Population, Hepat Mon. 2016 ; 16(2):e32427. doi: 10.5812/hepatmon.32427.

Copyright © 2016, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Dienstag JL. Hepatitis B virus infection. N Engl J Med. 2008; 359(14): 1486-500[DOI][PubMed]
  • 2. Lee WM. Hepatitis B virus infection. N Engl J Med. 1997; 337(24): 1733-45[DOI][PubMed]
  • 3. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004; 11(2): 97-107[PubMed]
  • 4. Liu Q, Song Y, Zhou Y, Qiao L. A useful agent for chemoprevention of hepatocellular carcinoma? Cancer Biol Ther. 2006; 5(12): 1674-6[PubMed]
  • 5. Hadziyannis SJ, Papatheodoridis GV, Vassilopoulos D. Precore mutant chronic hepatitis B - approach to management. MedGenMed. 2003; 5(4): 1[PubMed]
  • 6. Lai CL, Ratziu V, Yuen MF, Poynard T. Viral hepatitis B. Lancet. 2003; 362(9401): 2089-94[DOI][PubMed]
  • 7. Khanizadeh S, Ravanshad M, Mohebbi SR, Naghoosi H, Abrahim Tahaei M, Mousavi Nasab SD, et al. Polymorphisms within the Promoter Region of the Gamma Interferon (IFN-gamma) Receptor1 Gene are Associated with the Susceptibility to Chronic HBV Infection in an Iranian Population. Hepat Mon. 2012; 12(11)[DOI][PubMed]
  • 8. Karimi MH, Yaghobi R, Arjmandi K, Geramizadeh B, Nikeghbalian S, Malekhosseini SA. Cytokine gene polymorphisms and viral hepatitis infections in kidney transplant recipients. Lab Medicine. 2013; 44(2): 114-20
  • 9. Behelgardi A, Hosseini SM, Mohebbi SR, Azimzadeh P, Derakhshani S, Karimi K, et al. A Study on Genetic Association of Interleukin-16 Single Nucleotide Polymorphism (rs1131445) With Chronic Hepatitis B Virus Infection in Iranian Patients. Jundishapur J Microbiol. 2015; 8(11)
  • 10. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol. 2004; 22: 929-79[DOI][PubMed]
  • 11. Tsukamoto H. Is interleukin-10 antifibrogenic in chronic liver injury? Hepatology. 1998; 28(6): 1707-9[DOI][PubMed]
  • 12. Fonseca C, Lindahl GE, Ponticos M, Sestini P, Renzoni EA, Holmes AM, et al. A polymorphism in the CTGF promoter region associated with systemic sclerosis. N Engl J Med. 2007; 357(12): 1210-20[DOI][PubMed]
  • 13. Yang J, Li CR, Li YB, Li RX, Sun LB, Huang HJ, et al. [The correlation between Kawasaki disease and polymorphisms of Tumor necrosis factor alpha and interleukin-10 gene promoter]. Zhonghua Er Ke Za Zhi. 2003; 41(8): 598-602[PubMed]
  • 14. Eskdale J, Kube D, Tesch H, Gallagher G. Mapping of the human IL10 gene and further characterization of the 5' flanking sequence. Immunogenetics. 1997; 46(2): 120-8[PubMed]
  • 15. Hurme M, Lahdenpohja N, Santtila S. Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases. Ann Med. 1998; 30(5): 469-73[PubMed]
  • 16. D'Alfonso S, Rampi M, Rolando V, Giordano M, Momigliano-Richiardi P. New polymorphisms in the IL-10 promoter region. Genes Immun. 2000; 1(3): 231-3[DOI][PubMed]
  • 17. Gibson AW, Edberg JC, Wu J, Westendorp RG, Huizinga TW, Kimberly RP. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol. 2001; 166(6): 3915-22[PubMed]
  • 18. Kube D, Rieth H, Eskdale J, Kremsner PG, Gallagher G. Structural characterisation of the distal 5' flanking region of the human interleukin-10 gene. Genes Immun. 2001; 2(4): 181-90[DOI][PubMed]
  • 19. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997; 24(1): 1-8[PubMed]
  • 20. Reuss E, Fimmers R, Kruger A, Becker C, Rittner C, Hohler T. Differential regulation of interleukin-10 production by genetic and environmental factors--a twin study. Genes Immun. 2002; 3(7): 407-13[DOI][PubMed]
  • 21. Eskdale J, Kube D, Gallagher G. A second polymorphic dinucleotide repeat in the 5' flanking region of the human IL10 gene. Immunogenetics. 1996; 45(1): 82-3[PubMed]
  • 22. Koss K, Fanning GC, Welsh KI, Jewell DP. Interleukin-10 gene promoter polymorphism in English and Polish healthy controls. Polymerase chain reaction haplotyping using 3' mismatches in forward and reverse primers. Genes Immun. 2000; 1(5): 321-4[DOI][PubMed]
  • 23. Tountas NA, Cominelli F. Identification and initial characterisation of two polymorphisms in the human interleukin-10 promoter. Eur Cytokine Netw. 1996; 7: 578
  • 24. Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RG, Huizinga TW. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci U S A. 1998; 95(16): 9465-70[PubMed]
  • 25. Miyazoe S, Hamasaki K, Nakata K, Kajiya Y, Kitajima K, Nakao K, et al. Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus. Am J Gastroenterol. 2002; 97(8): 2086-92[DOI][PubMed]
  • 26. Edwards-Smith CJ, Jonsson JR, Purdie DM, Bansal A, Shorthouse C, Powell EE. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology. 1999; 30(2): 526-30[DOI][PubMed]
  • 27. Afzal MS, Tahir S, Salman A, Baig TA, Shafi T, Zaidi NU, et al. Analysis of interleukin-10 gene polymorphisms and hepatitis C susceptibility in Pakistan. J Infect Dev Ctries. 2011; 5(6): 473-9[PubMed]
  • 28. Peng XM, Huang YS, Ma HH, Gu L, Xie QF, Gao ZL. Interleukin-10 promoter polymorphisms are associated with the mode and sequel of HBeAg seroconversion in patients with chronic hepatitis B virus infection. Liver Int. 2006; 26(3): 326-33[DOI][PubMed]
  • 29. Cheong JY, Cho SW, Hwang IL, Yoon SK, Lee JH, Park CS, et al. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms. J Gastroenterol Hepatol. 2006; 21(7): 1163-9[DOI][PubMed]
  • 30. Migita K, Miyazoe S, Maeda Y, Daikoku M, Abiru S, Ueki T, et al. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection--association between TGF-beta1 polymorphisms and hepatocellular carcinoma. J Hepatol. 2005; 42(4): 505-10[DOI][PubMed]
  • 31. Bagheri MMH, Sharifi Z, Sanati MH, Shahzadeh FA, Farhangnia M. The survey on-592 polymorphism of interlukin-10 in hepatitis b virus infected patients. J Isfahan Med School. 2014; 31(271): 1-8
  • 32. Gao QJ, Liu DW, Zhang SY, Jia M, Wang LM, Wu LH, et al. Polymorphisms of some cytokines and chronic hepatitis B and C virus infection. World J Gastroenterol. 2009; 15(44): 5610-9[PubMed]
  • 33. Yan Z, Tan W, Zhao W, Dan Y, Wang X, Mao Q, et al. Regulatory polymorphisms in the IL-10 gene promoter and HBV-related acute liver failure in the Chinese population. J Viral Hepat. 2009; 16(11): 775-83[DOI][PubMed]
  • 34. Persico M, De Renzo A, Persico E, Torella D, Rotoli B, Torella R. Chronic liver disease and lymphoproliferative disorders in HCV-positive patients: a working hypothesis. J Hepatol. 1998; 29(5): 857-8[PubMed]
  • 35. Xie HY, Wang WL, Yao MY, Yu SF, Feng XN, Jin J, et al. Polymorphisms in cytokine genes and their association with acute rejection and recurrence of hepatitis B in Chinese liver transplant recipients. Arch Med Res. 2008; 39(4): 420-8[DOI][PubMed]
  • 36. Ollier WE. Cytokine genes and disease susceptibility. Cytokine. 2004; 28(4-5): 174-8[DOI][PubMed]
  • 37. Hohler T, Reuss E, Freitag CM, Schneider PM. A functional polymorphism in the IL-10 promoter influences the response after vaccination with HBsAg and hepatitis A. Hepatology. 2005; 42(1): 72-6[DOI][PubMed]
  • 38. Yee LJ, Tang J, Gibson AW, Kimberly R, Van Leeuwen DJ, Kaslow RA. Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection. Hepatology. 2001; 33(3): 708-12[DOI][PubMed]
  • 39. Oleksyk TK, Thio CL, Truelove AL, Goedert JJ, Donfield SM, Kirk GD, et al. Single nucleotide polymorphisms and haplotypes in the IL10 region associated with HCV clearance. Genes Immun. 2005; 6(4): 347-57[DOI][PubMed]
  • 40. Powell EE, Edwards-Smith CJ, Hay JL, Clouston AD, Crawford DH, Shorthouse C, et al. Host genetic factors influence disease progression in chronic hepatitis C. Hepatology. 2000; 31(4): 828-33[DOI][PubMed]
  • 41. Constantini PK, Wawrzynowicz-Syczewska M, Clare M, Boron-Kaczmarska A, McFarlane IG, Cramp ME, et al. Interleukin-1, interleukin-10 and tumour necrosis factor-alpha gene polymorphisms in hepatitis C virus infection: an investigation of the relationships with spontaneous viral clearance and response to alpha-interferon therapy. Liver. 2002; 22(5): 404-12[PubMed]
  • 42. Truelove AL, Oleksyk TK, Shrestha S, Thio CL, Goedert JJ, Donfield SM, et al. Evaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcome. Int J Immunogenet. 2008; 35(3): 255-64[DOI][PubMed]
  • 43. Srivastava M, Ranjan A, Choudhary JK, Tripathi MK, Verma S, Dixit VK, et al. Role of proinflammatory cytokines (interferon gamma) and anti-inflammatory cytokine (interleukin-10) gene polymorphisms in chronic hepatitis B infection: an Indian scenario. J Interferon Cytokine Res. 2014; 34(7): 547-51[DOI][PubMed]
  • 44. Wang S, Huang D, Sun S, Ma W, Zhen Q. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis B to interferon alfa. Virol J. 2011; 8: 28[DOI][PubMed]
  • 45. Ghaleh Baghi S, Alavian SM, Mehrnoush L, Salimi S. Impact of the IL-10 Promoter Gene Polymorphisms in the Severity of Chronic Hepatitis B Infection. Hepat Mon. 2015; 15(7)[DOI][PubMed]
  • 46. Sofian M, Kalantar E, Aghakhani A, Hosseini S, Banifazl M, Eslamifar A, et al. No correlation between interleukin-10 gene promoter polymorphisms and hepatitis B virus infection outcome. Hepat Mon. 2013; 13(5)[DOI][PubMed]
  • 47. Kusumoto K, Uto H, Hayashi K, Takahama Y, Nakao H, Suruki R, et al. Interleukin-10 or tumor necrosis factor-alpha polymorphisms and the natural course of hepatitis C virus infection in a hyperendemic area of Japan. Cytokine. 2006; 34(1-2): 24-31[DOI][PubMed]
  • 48. Chuang JY, Yang SS, Lu YT, Hsieh YY, Chen CY, Chang SC, et al. IL-10 promoter gene polymorphisms and sustained response to combination therapy in Taiwanese chronic hepatitis C patients. Dig Liver Dis. 2009; 41(6): 424-30[DOI][PubMed]
  • 49. Shin HD, Park BL, Kim LH, Jung JH, Kim JY, Yoon JH, et al. Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma. Hum Mol Genet. 2003; 12(8): 901-6[PubMed]
  • 50. Wu JF, Ni YH, Lin YT, Lee TJ, Hsu SH, Chen HL, et al. Human interleukin-10 genotypes are associated with different precore/core gene mutation patterns in children with chronic hepatitis B virus infection. J Pediatr. 2011; 158(5): 808-13[DOI][PubMed]
  • 51. Lu YL, Wu X, Huang HL, Dai LC. Allele polymorphisms of interleukin-10 and hepatitis B, C virus infection. Chin Med J (Engl). 2010; 123(10): 1338-44[PubMed]
  • 52. Zhang PA, Li Y, Yang XS. [Associated study on interleukin 10 gene promoter polymorphisms related to hepatitis B virus infection in Chinese Han population]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2006; 23(4): 410-4[PubMed]
  • 53. Mangia A, Santoro R, Piattelli M, Pazienza V, Grifa G, Iacobellis A, et al. IL-10 haplotypes as possible predictors of spontaneous clearance of HCV infection. Cytokine. 2004; 25(3): 103-9[PubMed]
  • 54. Fickenscher H, Hor S, Kupers H, Knappe A, Wittmann S, Sticht H. The interleukin-10 family of cytokines. Trends Immunol. 2002; 23(2): 89-96[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments